HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Tapang Selected Research

Paul Tapang Research Topics

Disease

13Neoplasms (Cancer)
12/2012 - 01/2002
3Fibrosarcoma
07/2011 - 04/2006
2Carcinoma (Carcinomatosis)
07/2011 - 11/2003
2Edema (Dropsy)
04/2007 - 04/2006
1Multiple Myeloma
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2012
1Lymphoma (Lymphomas)
12/2012
1Hematologic Neoplasms (Hematological Malignancy)
12/2012
1Leukemia
12/2012
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2012
1Polyploidy
12/2012
1Colorectal Neoplasms (Colorectal Cancer)
10/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2012
1Hypertension (High Blood Pressure)
06/2009
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2007
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2006
1Glioma (Gliomas)
04/2006
1Corneal Neovascularization
04/2006
1Carcinogenesis
04/2005
1Sarcoma (Soft Tissue Sarcoma)
11/2003
1Neuroblastoma
11/2003

Drug/Important Bio-Agent (IBA)

5linifanibIBA
06/2012 - 04/2006
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2011 - 04/2007
2Proteins (Proteins, Gene)FDA Link
01/2016 - 07/2011
2Urea (Carbamide)FDA LinkGeneric
05/2012 - 06/2009
2Phosphotransferases (Kinase)IBA
04/2007 - 04/2006
1venetoclaxIBA
01/2016
1Bortezomib (Velcade)FDA Link
01/2016
1navitoclaxIBA
01/2016
1Pharmaceutical PreparationsIBA
01/2016
1src-Family KinasesIBA
12/2012
1Histones (Histone)IBA
12/2012
1Imatinib Mesylate (Gleevec)FDA Link
12/2012
1ilorasertibIBA
12/2012
1Irinotecan (Camptosar)FDA LinkGeneric
10/2012
1Glucose (Dextrose)FDA LinkGeneric
10/2012
1ThymidineIBA
10/2012
1Biomarkers (Surrogate Marker)IBA
06/2012
1diphenyl (biphenyl)IBA
05/2012
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2011
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2011
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2009
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2009
1Angiotensin Receptor AntagonistsIBA
06/2009
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
06/2009
1EnalaprilFDA LinkGeneric
06/2009
1Antihypertensive Agents (Antihypertensives)IBA
06/2009
1TransferasesIBA
04/2007
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2007
1Estradiol (Delestrogen)FDA LinkGeneric
04/2007
1Blood Proteins (Serum Proteins)IBA
04/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2006
1Small Interfering RNA (siRNA)IBA
04/2005
1Polo-Like Kinase 1IBA
04/2005
1AgarIBA
04/2005
1AminopeptidasesIBA
11/2003
1Antineoplastic Agents (Antineoplastics)IBA
11/2003
1O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
11/2003
1A357300IBA
11/2003
1Methionine (L-Methionine)FDA Link
11/2003
1EnzymesIBA
11/2003
1AmidesIBA
10/2003
1N- (1- (2,2- dimethyl- 1,3- dioxol- 4- yl)- 2- ((4,4- (trifluoromethoxyphenoxy)phenyl)sulfonyl)ethyl)- N- hydroxyformamideIBA
01/2002
1Matrix Metalloproteinase InhibitorsIBA
01/2002

Therapy/Procedure

2Therapeutics
10/2012 - 11/2003
1Intraperitoneal Injections
10/2012
1Aftercare (After-Treatment)
07/2011